Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Cell Reports. Medicine|May 21, 2026
Lung mucosal and systemic responses at single-cell resolution in an aerosolized Mycobacterium bovis BCG human challenge modelShuailin Li, Hazel Morrison, Mihaela Duta, et al.BMC Infectious Diseases|July 13, 2013
Detection of group a streptococcal pharyngitis by quantitative PCREileen M Dunne, Julia L Marshall, Ciara A Baker, et al.Plos Neglected Tropical Diseases|June 29, 2023
A human model of Buruli ulcer: The case for controlled human infection and considerations for selecting a Mycobacterium ulcerans challenge strainStephen Muhi, Joshua Osowicki, Daniel O'Brien, et al.Plos Neglected Tropical Diseases|February 5, 2025
Perceptions of a Buruli ulcer controlled human infection model: How, who, and why?Stephen Muhi, Simone Schmidt, Julia L Marshall, et al.Wellcome Open Research|October 10, 2024
A human model of Buruli ulcer: Provisional protocol for a Mycobacterium ulcerans controlled human infection studyStephen Muhi, Julia L Marshall, Daniel P O'Brien, et al.Plos Medicine|May 1, 2019
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trialZita-Rose Manjaly Thomas, Iman Satti, Julia L Marshall, et al.Plos Neglected Tropical Diseases|May 3, 2024
Mycobacterium ulcerans challenge strain selection for a Buruli ulcer controlled human infection modelStephen Muhi, Andrew H Buultjens, Jessica L Porter, et al.Scientific Reports|May 13, 2022
Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical studyMorven Wilkie, Rachel Tanner, Daniel Wright, et al.Vaccines|October 26, 2024
Mtb-Specific HLA-E-Restricted T Cells Are Induced during Mtb Infection but Not after BCG Administration in Non-Human Primates and HumansLinda Voogd, Marjolein van Wolfswinkel, Iman Satti, et al.The Lancet. Infectious Diseases|November 28, 2023
Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trialAnne Wajja, Beatrice Nassanga, Agnes Natukunda, et al.Pageof 2